| Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis D Baeten, J Sieper, J Braun, X Baraliakos, M Dougados, P Emery, ... New England journal of medicine 373 (26), 2534-2548, 2015 | 1122 | 2015 |
| Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility Australo-Anglo-American Spondyloarthritis Consortium (TASC), ... Nature genetics 43 (8), 761-767, 2011 | 983 | 2011 |
| Activation of the transcription factor nuclear factor‐κB in human inflamed synovial tissue R Marok, PG Winyard, A Coumbe, ML Kus, K Gaffney, S Blades, PI Mapp, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1996 | 414 | 1996 |
| Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. K Gaffney, J Ledingham, JD Perry Annals of the rheumatic diseases 54 (5), 379-381, 1995 | 326 | 1995 |
| Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ... Arthritis & Rheumatology 71 (2), 258-270, 2019 | 307 | 2019 |
| Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 A Cortes, SL Pulit, PJ Leo, JJ Pointon, PC Robinson, MH Weisman, ... Nature communications 6 (1), 7146, 2015 | 281 | 2015 |
| Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 244 | 2019 |
| Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years AYN Lim, K Gaffney, DGI Scott Rheumatology 44 (8), 1051-1055, 2005 | 214 | 2005 |
| Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers JL Jorizzo, JL Abernethy, WL White, HC Mangelsdorf, CC Zouboulis, ... Journal of the American Academy of Dermatology 32 (6), 968-976, 1995 | 187 | 1995 |
| Quantification of rheumatoid synovitis by magnetic resonance imaging K Gaffney, J Cookson, D Blake, A Coumbe, S Blades Arthritis & Rheumatism: Official Journal of the American College of …, 1995 | 184 | 1995 |
| Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging K Gaffney, J Cookson, S Blades, A Coumbe, D Blake Annals of the rheumatic diseases 57 (3), 152-157, 1998 | 168 | 1998 |
| Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? MP Sykes, H Doll, R Sengupta, K Gaffney Rheumatology 54 (12), 2283-2284, 2015 | 132 | 2015 |
| Chronic periaortitis RN Jois, K Gaffney, T Marshall, DGI Scott Rheumatology 43 (11), 1441-1446, 2004 | 117 | 2004 |
| Clinical utility of random anti–tumor necrosis factor drug–level testing and measurement of antidrug antibodies on the long‐term treatment response in rheumatoid arthritis M Jani, H Chinoy, RB Warren, CEM Griffiths, D Plant, B Fu, AW Morgan, ... Arthritis & rheumatology 67 (8), 2011-2019, 2015 | 115 | 2015 |
| ~ 1-Proteinase Inhibitor, Elastase Activity, and Lung Disease Severity in Cystic Fibrosis CM O'Connor, K Gaffney, J Keane, A Southey, N Byrne, S O'Mahoney, ... American Review of Respiratory Disease 148, 1665-1665, 1993 | 107 | 1993 |
| BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology A Keat, N Barkham, A Bhalla, K Gaffney, H Marzo-Ortega, S Paul, ... Rheumatology 44 (7), 939-947, 2005 | 104 | 2005 |
| Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled … JJ Solomon, SK Danoff, FA Woodhead, S Hurwitz, R Maurer, I Glaspole, ... The Lancet Respiratory Medicine 11 (1), 87-96, 2023 | 102 | 2023 |
| Recognition of inflammatory back pain and ankylosing spondylitis in primary care RN Jois, AJ Macgregor, K Gaffney Rheumatology 47 (9), 1364-1366, 2008 | 102 | 2008 |
| The prevalence of axial spondyloarthritis in the UK: a cross-sectional cohort study L Hamilton, A Macgregor, A Toms, V Warmington, E Pinch, K Gaffney BMC musculoskeletal disorders 16, 1-5, 2015 | 83 | 2015 |
| Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction RBM Landewé, D van der Heijde, M Dougados, X Baraliakos, ... Annals of the rheumatic diseases 79 (7), 920-928, 2020 | 77 | 2020 |
Raj SenguptaRoyal National Hospital for Rheumatic Diseases在 nhs.net 的电子邮件经过验证
